Andic Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 21 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.50 M
- Revenue Growth 1.44%
- Profit Growth -1083.33%
- Ebitda -32.08%
- Net Worth -9.01%
- Total Assets -4.93%
About Andic Lifesciences
Andic Lifesciences Private Limited (ALPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 December 2003 and has a history of 21 years and one month. Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.50 M.
Jyoti Agrawal and Anjani Agrawal serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231GJ2003PTC043387
-
Company No.
043387
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
23 Dec 2003
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Andic Lifesciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jyoti Agrawal
|
Managing Director | 23-Dec-2003 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Anjani Agrawal
|
Whole-Time Director | 13-Jun-2019 | Current |
Financial Performance of Andic Lifesciences.
Andic Lifesciences Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.44% increase. The company also saw a substantial fall in profitability, with a 1083.33% decrease in profit. The company's net worth dipped by a decrease of 9.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Andic Lifesciences?
In 2023, Andic Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Malody Healthcare LimitedJyoti Agrawal and Anjani Agrawal are mutual person
-
Acacia Biotech LimitedJyoti Agrawal is a mutual person
Charges (Loans)
₹0.50 M
₹0
Charges Breakdown by Lending Institutions
- Central Bank Of India : 0.05 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Nov 2004 | Central Bank Of India | ₹0.50 M | Open |
How Many Employees Work at Andic Lifesciences?
Unlock and access historical data on people associated with Andic Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Andic Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Andic Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
